Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Pamela D. Jones"'
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 38, Iss 6, Pp 3162-3169 (2024)
Abstract Background Information regarding response rate to tigilanol tiglate for mast cell tumors in dogs is limited. Objectives Report the response rate and durability of tigilanol tiglate intratumoral treatment in dogs with mast cell tumors present
Externí odkaz:
https://doaj.org/article/41a3474d48f841478cefbe13b6b24675
Publikováno v:
Veterinary Week; 10/28/2024, p17-17, 1p
Autor:
Graham K. Brown, Jessica R. Finlay, Rodney C. Straw, Joy Y. Ziea, Becky Leung, Kathleen O'Connell, Maurine J. Thomson, Justine E. Campbell, Pamela D. Jones, Paul Reddell
Publikováno v:
Frontiers in Veterinary Science, Vol 9 (2022)
Mast cell tumours (MCTs) are common canine skin neoplasia. While they generally occur as single tumours, multiple synchronous MCTs (msMCTs) of de novo/non-metastatic origin are reported in a proportion of the patient population. Where there is no evi
Externí odkaz:
https://doaj.org/article/07a76564ce0745ec831b10b7fb56ca25
Autor:
Thomas R. De Ridder, Justine E. Campbell, Cheryl Burke‐Schwarz, David Clegg, Emily L. Elliot, Samuel Geller, Wendy Kozak, Stephen T. Pittenger, Jennifer B. Pruitt, Jocelyn Riehl, Julie White, Melissa L. Wiest, Chad M. Johannes, John Morton, Pamela D. Jones, Peter F. Schmidt, Victoria Gordon, Paul Reddell
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 35, Iss 1, Pp 415-429 (2021)
Abstract Objective To evaluate the efficacy and safety of tigilanol tiglate (TT) for local intratumoral treatment of mast cell tumors (MCTs) in dogs. Methods A randomized controlled clinical study in 2 phases involving 123 dogs with cytologically dia
Externí odkaz:
https://doaj.org/article/1df0a2eb05904e1abae36124d5866f9c
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 35, Iss 1, Pp 451-455 (2021)
Abstract Background Tigilanol tiglate (TT) is a novel small molecule approved by the European Medicines Agency for intratumoral treatment of mast cell tumors (MCTs) in dogs. In a randomized controlled clinical efficacy and safety study in the United
Externí odkaz:
https://doaj.org/article/30866ecda9b14defb6f8f3736644451e
Autor:
Paul Reddell, Thomas R. De Ridder, John M. Morton, Pamela D. Jones, Justine E. Campbell, Graham Brown, Chad M. Johannes, Peter F. Schmidt, Victoria Gordon
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 35, Iss 1, Pp 430-441 (2021)
Abstract Background Tigilanol tiglate (TT) is a novel small molecule for intratumoral treatment of nonmetastatic mast cell tumors (MCTs) in dogs. In a randomized controlled clinical study, 75% of dogs that received a single TT treatment achieved comp
Externí odkaz:
https://doaj.org/article/ce30c3d533e44be39a8c2c5a3b666f9e
Autor:
Graham K. Brown, Justine E. Campbell, Pamela D. Jones, Thomas R. De Ridder, Paul Reddell, Chad M. Johannes
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Canine high-grade mast cell tumours (HGMCT) are associated with a poor prognosis, are inherently more invasive, and have higher rates of local recurrence. The primary aim of this retrospective study was to assess the efficacy of intratumoural tigilan
Externí odkaz:
https://doaj.org/article/588245b789e64fd7ac070eb92bf27d65
Autor:
Pamela D. Jones, Pamela A. Gordon
Publikováno v:
Pastoral Psychology. 72:277-288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73419346a157a7a4463f3e6ba87e8064
https://doi.org/10.1007/s11089-022-01034-y
https://doi.org/10.1007/s11089-022-01034-y
Autor:
Chad M Johannes, Justine E Campbell, Pamela D Jones, Graham Brown, John M. Morton, Thomas R De Ridder, Peter Frederick Schmidt, Victoria A. Gordon, Paul Reddell
Publikováno v:
Journal of Veterinary Internal Medicine
Background Tigilanol tiglate (TT) is a novel small molecule for intratumoral treatment of nonmetastatic mast cell tumors (MCTs) in dogs. In a randomized controlled clinical study, 75% of dogs that received a single TT treatment achieved complete reso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7c37514613700c152542878cd54eb3c
http://europepmc.org/articles/PMC7848365
http://europepmc.org/articles/PMC7848365
Publikováno v:
Journal of Veterinary Internal Medicine
Background Tigilanol tiglate (TT) is a novel small molecule approved by the European Medicines Agency for intratumoral treatment of mast cell tumors (MCTs) in dogs. In a randomized controlled clinical efficacy and safety study in the United States, 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e613b2fd464039bd81a53ed3d8d62958
http://europepmc.org/articles/PMC7848364
http://europepmc.org/articles/PMC7848364